Priti Tewari

11PUBLICATIONS
31CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Infant and child healthRegenerative medicine (incl. stem cells)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Aug 08, 2026
Resolution of Neuroblastoma-Related Opsoclonus-Myoclonus Ataxia Syndrome Following Tandem High-Dose Chemotherapy With Autologous Hematopoietic Stem Cell Transplantation and Extensive Intravenous Immunoglobulin.

|Mar 27, 2026
Gemcitabine, Docetaxel, Melphalan, Carboplatin as Part of Sequential Cycles of High-Dose Chemotherapy With Autologous Hematopoietic Stem-Cell Rescue for Multiply Relapsed/Refractory Pediatric Germ Cell Tumors.

Maria Frost, Olayinka Okeleji, Amr Elgehiny

|Jan 26, 2026
Immune-related toxicity profile after haematopoietic stem cell transplantation in patients with B-ALL given combination immunotherapy with rituximab, inotuzumab and blinatumomab.

Olayinka Okeleji, David McCall, Branko Cuglievan

|Oct 06, 2025
A Virtual Wellness Program to Enhance Well-being for Pediatric Oncology Staff during the COVID-19 Pandemic.

Karen M Moody, Maria Chang Swartz, Zachary Gresham

|Feb 24, 2025
Post transplant maintenance therapy with newly FDA-approved revumenib for high-risk KMT2Ar acute leukemia.

Olayinka Okeleji, David McCall, Amber Gibson

|Mar 13, 2024
Biological Markers of High-Risk Childhood Acute Lymphoblastic Leukemia.

Jiasen He, Faryal Munir, Samanta Catueno

Pageof 2

Frequent Collaborators

5 joint publications

Irtiza N Sheikh

4 joint publications

Sajad Khazal

3 joint publications

Olayinka Okeleji

3 joint publications

Amber Gibson